Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R PELKONEN

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Diabetes Care|July 1, 1993
Seven years of remission in a type I diabetic patientV A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Regulatory Toxicology and Pharmacology : RTP|November 30, 2013
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshopJos G Bessems, George Loizou, Kannan Krishnan, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Diabetes Care|July 1, 1993
Seven years of remission in a type I diabetic patientV A Koivisto, M Leirisalo-Repo, P Ebeling, et al.
Current Drug Metabolism|February 3, 2007
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liverZoe E Barter, Martin K Bayliss, Philip H Beaune, et al.
Regulatory Toxicology and Pharmacology : RTP|November 30, 2013
PBTK modelling platforms and parameter estimation tools to enable animal-free risk assessment: recommendations from a joint EPAA--EURL ECVAM ADME workshopJos G Bessems, George Loizou, Kannan Krishnan, et al.
Pageof 9